marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q1
added 05-09-2024
Pacific Biosciences of California Balance Sheet 2011-2024 | PACB
Annual Balance Sheet Pacific Biosciences of California
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-139 M | -275 M | -403 M | -39.6 M | 2.12 M | 79.3 M | 43.5 M | 54.6 M | 30 M | 42.6 M | 73.2 M | -43.8 M | -55.9 M |
Long Term Debt |
31.6 M | 41.1 M | 50 M | 37.7 M | 15.9 M | 14.7 M | 13.6 M | 16.1 M | 14.9 M | 14.1 M | 13.3 M | - | - |
Long Term Debt Current |
9.59 M | 8.89 M | 7.71 M | 4.33 M | 3.84 M | - | - | - | - | - | - | 173 K | 140 K |
Total Non Current Liabilities |
- | - | - | - | 43.9 M | 29.3 M | 29.3 M | 19.4 M | 19.4 M | 38.1 M | 44.4 M | 5.56 M | 7.48 M |
Total Current Liabilities |
95 M | 263 M | 71.7 M | 38.5 M | 49.2 M | 26.9 M | 28.6 M | 33.8 M | 38.2 M | 31.5 M | 22.6 M | 14.7 M | 19.4 M |
Total Liabilities |
1.04 B | 1.2 B | 1.22 B | 78.5 M | 93.1 M | 56.2 M | 58 M | 53.2 M | 57.6 M | 69.6 M | 67 M | 20.3 M | 26.9 M |
Deferred Revenue |
16.3 M | 30.5 M | 11 M | 10.3 M | 7.61 M | 6.54 M | 6.32 M | 7.13 M | 17.6 M | 12.9 M | 11.7 M | 4.06 M | 6.58 M |
Retained Earnings |
-1.84 B | -1.53 B | -1.22 B | - | -1.07 B | -982 M | -880 M | -788 M | -713 M | -681 M | -615 M | -536 M | -442 M |
Total Assets |
1.75 B | 1.77 B | 2.01 B | 414 M | 148 M | 170 M | 144 M | 138 M | 131 M | 125 M | 136 M | 130 M | 218 M |
Cash and Cash Equivalents |
180 M | 325 M | 461 M | 81.6 M | 29.6 M | 18.8 M | 16.5 M | 16.8 M | 33.6 M | 36.4 M | 26.4 M | 46.5 M | 58.9 M |
Book Value |
701 M | 563 M | 791 M | 335 M | 54.9 M | 114 M | 86.1 M | 84.7 M | 73.5 M | 54.9 M | 69.2 M | 109 M | 191 M |
Total Shareholders Equity |
701 M | 563 M | 791 M | 335 M | 54.9 M | 114 M | 86.1 M | 84.7 M | 73.5 M | 54.9 M | 69.2 M | 109 M | 191 M |
All numbers in USD currency
Quarterly Balance Sheet Pacific Biosciences of California
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
29 M | 31.6 M | 34.1 M | 36.6 M | 897 M | 41.1 M | 897 M | 896 M | 896 M | 896 M | 896 M | 896 M | 896 M | 37.7 M | 37.7 M | 37.7 M | 37.7 M | 15.9 M | 15.5 M | 15.2 M | 14.9 M | 14.7 M | 14.4 M | 14.1 M | 13.9 M | 13.6 M | - | - | - | 16.1 M | - | - | - | - | - | - | - | 14.1 M | - | - | - | 13.3 M | - | - | 2.56 M | 2.61 M | 2.66 M | 2.7 M | 2.75 M | 2.79 M | 2.79 M | 2.79 M | 2.79 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.02 B | 1.04 B | 1.13 B | 1.21 B | 1.2 B | 1.2 B | 1.19 B | 1.19 B | 1.2 B | 1.22 B | 1.19 B | 988 M | 972 M | 78.5 M | 78.5 M | 78.5 M | 78.5 M | 93.1 M | 93.1 M | 93.1 M | 93.1 M | 56.2 M | 56.2 M | 56.2 M | 56.2 M | 58 M | 58 M | 58 M | 58 M | 53.2 M | 53.2 M | 53.2 M | 53.2 M | 57.6 M | 57.6 M | 57.6 M | 57.6 M | 69.4 M | 69.6 M | 69.6 M | 69.6 M | 67 M | 67 M | 67 M | 67 M | 20.3 M | 20.3 M | 20.3 M | 20.3 M | 26.9 M | 26.9 M | 26.9 M | 26.9 M |
Deferred Revenue |
17.3 M | 16.3 M | 22.4 M | 25 M | 30.9 M | 30.5 M | 30.7 M | 32.1 M | 12.7 M | 11 M | 9.77 M | 9.53 M | 9.61 M | 8.72 M | 8.72 M | 8.72 M | 8.72 M | 7.61 M | 7.61 M | 7.61 M | 7.61 M | 6.54 M | 6.54 M | 6.54 M | 6.54 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.4 M | 3.35 M | 2.96 M | 3.38 M | 3.56 M | 3.38 M | 3.38 M | 4.24 M | 4.24 M | 4.24 M | 4.24 M |
Retained Earnings |
-1.92 B | -1.84 B | -1.76 B | -1.69 B | -1.62 B | -1.53 B | -1.45 B | -1.37 B | -1.3 B | -1.22 B | -1.15 B | -1.17 B | -1.12 B | -1.04 B | -1.04 B | -1.04 B | -1.04 B | -1.07 B | -1.07 B | -1.07 B | -1.07 B | -982 M | -982 M | -982 M | -982 M | -880 M | -880 M | -880 M | -880 M | -788 M | -788 M | -788 M | -788 M | -713 M | -713 M | -713 M | -713 M | -681 M | -681 M | -681 M | -681 M | -615 M | -615 M | -615 M | -615 M | -536 M | -536 M | -536 M | -536 M | -442 M | -442 M | -442 M | -442 M |
Total Assets |
1.67 B | 1.75 B | 1.9 B | 1.85 B | 1.9 B | 1.77 B | 1.82 B | 1.88 B | 1.94 B | 2.01 B | 2.03 B | 1.25 B | 1.25 B | 414 M | 414 M | 414 M | 414 M | 148 M | 148 M | 148 M | 148 M | 170 M | 170 M | 170 M | 170 M | 144 M | 144 M | 144 M | 144 M | 138 M | 138 M | 138 M | 138 M | 131 M | 131 M | 131 M | 131 M | 124 M | 125 M | 125 M | 125 M | 136 M | 136 M | 136 M | 136 M | 130 M | 130 M | 130 M | 130 M | 218 M | 218 M | 218 M | 218 M |
Cash and Cash Equivalents |
76.6 M | 180 M | 386 M | 209 M | 354 M | 325 M | 304 M | 310 M | 429 M | 461 M | 425 M | 460 M | 932 M | 81.6 M | 81.6 M | 81.6 M | 81.6 M | 29.6 M | 29.6 M | 29.6 M | 29.6 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 36.4 M | 36.4 M | 36.4 M | 36.4 M | 26.4 M | 26.4 M | 26.4 M | 26.4 M | 46.5 M | 46.5 M | 46.5 M | 46.5 M | 58.9 M | 58.9 M | 58.9 M | 58.9 M |
Book Value |
649 M | 701 M | 764 M | 642 M | 692 M | 563 M | 627 M | 682 M | 735 M | 791 M | 841 M | 258 M | 281 M | 335 M | 335 M | 335 M | 335 M | 54.9 M | 54.9 M | 54.9 M | 54.9 M | 114 M | 114 M | 114 M | 114 M | 86.1 M | 86.1 M | 86.1 M | 86.1 M | 84.7 M | 84.7 M | 84.7 M | 84.7 M | 73.5 M | 73.5 M | 73.5 M | 73.5 M | 54.9 M | 54.9 M | 54.9 M | 54.9 M | 69.2 M | 69.2 M | 69.2 M | 69.2 M | 109 M | 109 M | 109 M | 109 M | 191 M | 191 M | 191 M | 191 M |
Total Shareholders Equity |
649 M | 701 M | 764 M | 642 M | 692 M | 563 M | 627 M | 682 M | 735 M | 791 M | 841 M | 258 M | 281 M | 335 M | 335 M | 335 M | 335 M | 54.9 M | 54.9 M | 54.9 M | 54.9 M | 114 M | 114 M | 114 M | 114 M | 86.1 M | 86.1 M | 86.1 M | 86.1 M | 84.7 M | 84.7 M | 84.7 M | 84.7 M | 73.5 M | 73.5 M | 73.5 M | 73.5 M | 54.9 M | 54.9 M | 54.9 M | 54.9 M | 69.2 M | 69.2 M | 69.2 M | 69.2 M | 109 M | 109 M | 109 M | 109 M | 191 M | 191 M | 191 M | 191 M |
All numbers in USD currency